TOWARDS ENZYME THERAPY IN GM2 GANGLIOSIDOSIS - EXTRA-HEPATIC AND CNS TARGETING OF HUMAN BETA-HEXOSAMINIDASE IN THE CAT

被引:0
|
作者
RATTAZZI, MC
APPEL, AM
BAKER, HJ
机构
[1] SUNY BUFFALO,CHILDRENS HOSP,DEPT PEDIAT,BUFFALO,NY 14214
[2] UNIV ALABAMA,DEPT COMPARAT MED,BIRMINGHAM,AL 35233
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:526 / 526
页数:1
相关论文
共 50 条
  • [41] Development of protease-resistant modified human β-hexosaminidase B and evaluation of intracerebroventricular replacement effects on GM2 gangliosidosis model mice
    Kitakaze, Keisuke
    Tasaki, Chikako
    Mizutani, Yasumichi
    Sugiyama, Eiji
    Ikuo, Mariko
    Kamiya, Mako
    Setou, Mitsutoshi
    Urano, Yasuteru
    Itoh, Kohji
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S65 - S65
  • [42] LYSOSOMAL-ENZYME PRECURSORS IN HUMAN-FIBROBLASTS - ACTIVATION OF CATHEPSIN-D PRECURSOR INVITRO AND ACTIVITY OF BETA-HEXOSAMINIDASE-A PRECURSOR TOWARDS GANGLIOSIDE GM2
    HASILIK, A
    VONFIGURA, K
    CONZELMANN, E
    NEHRKORN, H
    SANDHOFF, K
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 125 (02): : 317 - 321
  • [43] GM2-GANGLIOSIDOSIS-B1 VARIANT - ANALYSIS OF BETA-HEXOSAMINIDASE ALPHA-GENE MUTATIONS IN 11 PATIENTS FROM A DEFINED REGION IN PORTUGAL
    DOSSANTOS, MR
    TANAKA, A
    MIRANDA, MCS
    RIBEIRO, MG
    MAIA, M
    SUZUKI, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 886 - 890
  • [44] GANGLIOSIDE GM2 LEVELS IN HUMAN-MELANOMA CELLS - INVERSE CORRELATION WITH LYSOSOMAL BETA-HEXOSAMINIDASE-A ACTIVITY
    HOON, DSB
    KABACK, MM
    LIMSTEELE, J
    TSUCHIDA, T
    MORTON, DL
    IRIE, RF
    BIOCHEMISTRY INTERNATIONAL, 1992, 27 (02): : 343 - 352
  • [45] HETEROZYGOSITY FOR THE DN ALLELE OF THE BETA-HEXOSAMINIDASE ALPHA-SUBUNIT GENE IDENTIFIED BY DIRECT DNA SEQUENCING IN A FAMILY WITH THE B1 VARIANT OF GM2-GANGLIOSIDOSIS
    WHITLEY, CB
    ANDERSON, RA
    MCIVOR, RS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 197 - 197
  • [46] Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis
    Ornaghi, Francesca
    Sala, Davide
    Tedeschi, Fabiana
    Maffia, Maria Chiara
    Bazzucchi, Martina
    Morena, Francesco
    Valsecchi, Manuela
    Aureli, Massimo
    Martino, Sabata
    Gritti, Angela
    NEUROBIOLOGY OF DISEASE, 2020, 134
  • [47] Intravenous Neonatal Gene Therapy Corrects GM2 Gangliosidosis in Sandhoff Mice for Long-Term, By Using AAV Viral Vector Expressing a New Hexosaminidase Variant
    Osmon, Karlaina J. L.
    Woodley, Evan
    Thompson, Patrick
    Ong, Katalina
    Karumuthil-Melethil, Subha
    Mark, Brian
    Mahuran, Don
    Gray, Steven J.
    Walia, Jagdeep S.
    MOLECULAR THERAPY, 2015, 23 : S283 - S284
  • [48] GM2-GANGLIOSIDOSIS-B1 VARIANT - A WIDE GEOGRAPHIC AND ETHNIC DISTRIBUTION OF THE SPECIFIC BETA-HEXOSAMINIDASE ALPHA-CHAIN MUTATION ORIGINALLY IDENTIFIED IN A PUERTO-RICAN PATIENT
    TANAKA, A
    OHNO, K
    SUZUKI, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (02) : 1015 - 1019
  • [49] MOLECULAR-BASIS OF ADULT-ONSET AND CHRONIC GM2 GANGLIOSIDOSES IN PATIENTS OF ASHKENAZI JEWISH ORIGIN - SUBSTITUTION OF SERINE FOR GLYCINE AT POSITION 269 OF THE ALPHA-SUBUNIT OF BETA-HEXOSAMINIDASE
    PAW, BH
    KABACK, MM
    NEUFELD, EF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) : 2413 - 2417
  • [50] HETEROZYGOSITY FOR THE DN ALLELE (G533--]A) OF THE BETA-HEXOSAMINIDASE ALPHA-SUBUNIT GENE IDENTIFIED BY DIRECT DNA SEQUENCING IN A FAMILY WITH THE B1 VARIANT OF GM2-GANGLIOSIDOSIS
    WHITLEY, CB
    ANDERSON, RA
    MCIVOR, RS
    NEUROPEDIATRICS, 1992, 23 (02) : 96 - 101